Back to CERS Stock Lookup

Cerus (CERS) – Press Releases

May 23, 2016 08:30 AM Health Canada Approves INTERCEPT Blood System for Plasma
May 3, 2016 04:01 PM Cerus Corporation Reports First Quarter 2016 Results
May 3, 2016 08:30 AM Cerus Announces that the Walter Reed National Military Medical Center Has Entered Into Routine Use of the INTERCEPT Blood System
Apr 28, 2016 08:30 AM Cerus to Present at the Deutsche Bank 41st Annual Health Care Conference on May 5, 2016
Apr 19, 2016 08:30 AM Cerus to Release First Quarter 2016 Results on May 3, 2016
Mar 16, 2016 08:30 AM Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma
Mar 15, 2016 08:30 AM Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA’s Revised Guidance Document on Bacterial Safety Standards for Platelets
Mar 9, 2016 08:00 AM Blood Centers of America Selects Cerus as its Supply Partner for Pathogen Reduction Technology
Mar 8, 2016 04:01 PM Cerus Corporation Reports Fourth Quarter and Year End 2015 Results
Mar 3, 2016 08:30 AM Cerus Enters Into Agreement With Banco de Sangre de Servicios Mutuos for the Use of INTERCEPT Platelets and Plasma in Puerto Rico to Sustain Blood Supply During Zika Epidemic
Mar 2, 2016 08:30 AM Cerus to Present at the Cowen and Company 36th Annual Health Care Conference on March 9, 2016
Feb 23, 2016 08:30 AM Cerus to Release Fourth Quarter and Year End 2015 Results on March 8, 2016
Feb 17, 2016 08:30 AM FDA’s Zika Guidance Document Allows Use of Pathogen Reduction to Reduce Transfusion Risk and Maintain Local Blood Availability
Feb 9, 2016 08:30 AM Cerus Enters Multi-Year Agreement with the American Red Cross for the Use of INTERCEPT Platelets and Plasma
Jan 14, 2016 08:30 AM AABB Authorizes Use of the INTERCEPT Blood System for Platelets to Reduce the Risk of Transfusion-Associated Graft Versus Host Disease
Jan 11, 2016 08:30 AM Cerus Appoints New Leadership for Europe, Middle East and Africa Region
Jan 7, 2016 08:30 AM Cerus and LifeShare Blood Centers Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Jan 5, 2016 08:30 AM Cerus Announces Agreement with Blood Systems, Inc. for the Use of INTERCEPT Platelets and Plasma
Dec 23, 2015 08:30 AM Cerus Announces Rhode Island Blood Center Enters into Agreement for the Use of INTERCEPT Platelets and Plasma
Dec 10, 2015 08:32 AM Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
Dec 9, 2015 08:30 AM Cerus Announces Agência Nacional de Vigilância Sanitária Approval of the INTERCEPT Blood System for Platelets and Plasma in Brazil
Dec 8, 2015 08:30 AM First Patient Enrolled in Cerus’ Phase IV PIPER Study
Dec 7, 2015 08:30 AM Cerus and Shepeard Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Dec 4, 2015 08:30 AM Cerus Announces Mississippi Valley Regional Blood Center Enters Into Agreement for the Use of INTERCEPT Platelets and Plasma
Dec 2, 2015 08:30 AM Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With the INTERCEPT Blood System for Platelets
Dec 1, 2015 08:30 AM Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Nov 5, 2015 04:01 PM Cerus Corporation Reports Third Quarter 2015 Results
Nov 5, 2015 08:30 AM Cerus and OneBlood Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Nov 3, 2015 08:30 AM Cerus to Present at the Stephens 2015 Fall Investment Conference on November 10, 2015
Nov 2, 2015 08:30 AM Cerus Corporation Announces CMS Issuance of Permanent P-Codes for Outpatient Hospital Billing of Pathogen-Reduced Platelets and Plasma
Oct 26, 2015 08:30 AM Cerus to Release Third Quarter 2015 Results on November 5, 2015
Oct 21, 2015 08:30 AM Cerus Corporation Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits
Oct 6, 2015 08:30 AM Cerus and the Community Blood Center of the Carolinas Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Sep 10, 2015 08:30 AM Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015
Sep 2, 2015 08:30 AM Cerus to Present at the Baird 2015 Healthcare Conference on September 9, 2015
Aug 6, 2015 04:01 PM Cerus Corporation Reports Second Quarter 2015 Results
Aug 4, 2015 08:30 AM Cerus to Present at the 2015 Wedbush PacGrow Healthcare Conference on August 11, 2015
Jul 21, 2015 08:30 AM Cerus and Unyts Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
Jul 13, 2015 08:30 AM Cerus and Bonfils Blood Center Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
Jul 6, 2015 08:30 AM Cerus to Release Second Quarter 2015 Results on August 6, 2015
Jul 1, 2015 08:30 AM Cerus to Present at Cantor Fitzgerald’s Inaugural Healthcare Conference on July 8, 2015
Jun 29, 2015 08:30 AM First INTERCEPT Pathogen Reduced Platelet Units Produced in the Continental US
Jun 8, 2015 08:30 AM Richard J. Benjamin, MD PhD Appointed as Cerus Corporation’s New Chief Medical Officer
May 5, 2015 04:01 PM Cerus Corporation Reports First Quarter 2015 Results
Apr 27, 2015 08:30 AM Cerus to Present at AABB Symposium on Pathogen-Reduced Components
Apr 22, 2015 08:30 AM Cerus to Release First Quarter 2015 Results on May 5, 2015
Mar 16, 2015 08:30 AM First Patient Enrolled in Cerus' TRUE Study With the American Red Cross to Address Chikungunya and Dengue Blood Safety Risks With Pathogen Reduced Platelets

Back to CERS Stock Lookup